MamanEBickelsJEphrosM, et al. Musculoskeletal manifestations of cat scratch disease. Clin Infect Dis. 2007;45(12):1535-1540.
3.
DonaDNai FovinoLMozzoE, et al. Osteomyelitis in cat-scratch disease: a never-ending dilemma-a case Report and literature review. Case Rep Pediatr. 2018;2018:1679306.
4.
SchattnerAUlielLDubinI. The cat did it: erythema nodosum and additional atypical presentations of Bartonella henselae infection in immunocompetent hosts. BMJ Case Rep. 2018;2018:bcr2017222511.
5.
BrunettiEFabbiMFerraioliG, et al. Cat-scratch disease in Northern Italy: atypical clinical manifestations in humans and prevalence of Bartonella infection in cats. Eur J Clin Microbiol Infect Dis. 2013;32(4):531-534.
6.
RolainJMBrouquiPKoehlerJEMaguinaCDolanMJRaoultD. Recommendations for treatment of human infections caused by Bartonella species. Antimicrob Agents Chemother. 2004;48(6):1921-1933.
SakellarisGKampitakisEKaramitopoulouE, et al. Cat scratch disease simulating a malignant process of the chest wall with coexistent osteomyelitis. Scand J Infect Dis. 2003;35(6-7):433-435.
9.
RidderGJBoedekerCCTechnau-IhlingKSanderA. Cat-scratch disease: otolaryngologic manifestations and management. Otolaryngol Head Neck Surg. 2005;132(3):353-358.
10.
Arango-FerreiraCCastanoJ. Parinaud’s oculoglandular syndrome in cat scratch disease. N Engl J Med. 2018;379(18):e31.
11.
SuhlerEBLauerAKRosenbaumJT. Prevalence of serologic evidence of cat scratch disease in patients with neuroretinitis. Ophthalmology. 2000;107(5):871-876.
12.
KawasakiAWilsonDL. Mass lesions of the posterior segment associated with Bartonella henselae. Br J Ophthalmol. 2003;87(2):248-249.